Rational design of HIV vaccines and microbicides: Report of the EUROPRISE annual conference 2011

Nicolas Ruffin, Marie Borggren, Zelda Euler, Fabio Fiorino, Katrijn Grupping, David Hallengärd, Aneele Javed, Kevin Mendonca, Charlotte Pollard, David Reinhart, Elisa Saba, Enas Sheik-Khalil, Annette Sköld, Serena Ziglio, Gabriella Scarlatti, Frances Gotch, Britta Wahren, Robin J. Shattock

Research output: Contribution to journalArticle

Abstract

Europrise is a Network of Excellence supported by the European Commission within the 6th Framework programme from 2007 to 2012. The Network has involved over 50 institutions from 13 European countries together with 3 industrial partners and 6 African countries. The Network encompasses an integrated program of research, training, dissemination and advocacy within the field of HIV vaccines and microbicides. A central and timely theme of the Network is the development of the unique concept of co-usage of vaccines and microbicides. Training of PhD students has been a major task, and some of these post-graduate students have here summarized novel ideas emanating from presentations at the last annual Europrise meeting in Prague. The latest data and ideas concerning HIV vaccine and microbicide studies are included in this review; these studies are so recent that the majority have yet to be published. Data were presented and discussed concerning novel immunisation strategies; microbicides and PrEP (alone and in combination with vaccines); mucosal transmission of HIV/SIV; mucosal vaccination; novel adjuvants; neutralizing antibodies; innate immune responses; HIV/SIV pathogenesis and disease progression; new methods and reagents. These - necessarily overlapping and thought-provoking topics - are comprehensively summarised by the Europrise students in the context of other recent exciting data.

Original languageEnglish
Pages (from-to)144
Number of pages1
JournalJournal of Translational Medicine
DOIs
Publication statusAccepted/In press - Jul 11 2012

Fingerprint

AIDS Vaccines
Annual Reports
Anti-Infective Agents
Students
Vaccines
HIV
Immunization
Combined Vaccines
Neutralizing Antibodies
Innate Immunity
Disease Progression
Vaccination
Education
Research

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ruffin, N., Borggren, M., Euler, Z., Fiorino, F., Grupping, K., Hallengärd, D., ... Shattock, R. J. (Accepted/In press). Rational design of HIV vaccines and microbicides: Report of the EUROPRISE annual conference 2011. Journal of Translational Medicine, 144. https://doi.org/10.1186/1479-5876-10-144

Rational design of HIV vaccines and microbicides : Report of the EUROPRISE annual conference 2011. / Ruffin, Nicolas; Borggren, Marie; Euler, Zelda; Fiorino, Fabio; Grupping, Katrijn; Hallengärd, David; Javed, Aneele; Mendonca, Kevin; Pollard, Charlotte; Reinhart, David; Saba, Elisa; Sheik-Khalil, Enas; Sköld, Annette; Ziglio, Serena; Scarlatti, Gabriella; Gotch, Frances; Wahren, Britta; Shattock, Robin J.

In: Journal of Translational Medicine, 11.07.2012, p. 144.

Research output: Contribution to journalArticle

Ruffin, N, Borggren, M, Euler, Z, Fiorino, F, Grupping, K, Hallengärd, D, Javed, A, Mendonca, K, Pollard, C, Reinhart, D, Saba, E, Sheik-Khalil, E, Sköld, A, Ziglio, S, Scarlatti, G, Gotch, F, Wahren, B & Shattock, RJ 2012, 'Rational design of HIV vaccines and microbicides: Report of the EUROPRISE annual conference 2011', Journal of Translational Medicine, pp. 144. https://doi.org/10.1186/1479-5876-10-144
Ruffin, Nicolas ; Borggren, Marie ; Euler, Zelda ; Fiorino, Fabio ; Grupping, Katrijn ; Hallengärd, David ; Javed, Aneele ; Mendonca, Kevin ; Pollard, Charlotte ; Reinhart, David ; Saba, Elisa ; Sheik-Khalil, Enas ; Sköld, Annette ; Ziglio, Serena ; Scarlatti, Gabriella ; Gotch, Frances ; Wahren, Britta ; Shattock, Robin J. / Rational design of HIV vaccines and microbicides : Report of the EUROPRISE annual conference 2011. In: Journal of Translational Medicine. 2012 ; pp. 144.
@article{ea362151761f4d218ae34b41db20ba2b,
title = "Rational design of HIV vaccines and microbicides: Report of the EUROPRISE annual conference 2011",
abstract = "Europrise is a Network of Excellence supported by the European Commission within the 6th Framework programme from 2007 to 2012. The Network has involved over 50 institutions from 13 European countries together with 3 industrial partners and 6 African countries. The Network encompasses an integrated program of research, training, dissemination and advocacy within the field of HIV vaccines and microbicides. A central and timely theme of the Network is the development of the unique concept of co-usage of vaccines and microbicides. Training of PhD students has been a major task, and some of these post-graduate students have here summarized novel ideas emanating from presentations at the last annual Europrise meeting in Prague. The latest data and ideas concerning HIV vaccine and microbicide studies are included in this review; these studies are so recent that the majority have yet to be published. Data were presented and discussed concerning novel immunisation strategies; microbicides and PrEP (alone and in combination with vaccines); mucosal transmission of HIV/SIV; mucosal vaccination; novel adjuvants; neutralizing antibodies; innate immune responses; HIV/SIV pathogenesis and disease progression; new methods and reagents. These - necessarily overlapping and thought-provoking topics - are comprehensively summarised by the Europrise students in the context of other recent exciting data.",
author = "Nicolas Ruffin and Marie Borggren and Zelda Euler and Fabio Fiorino and Katrijn Grupping and David Halleng{\"a}rd and Aneele Javed and Kevin Mendonca and Charlotte Pollard and David Reinhart and Elisa Saba and Enas Sheik-Khalil and Annette Sk{\"o}ld and Serena Ziglio and Gabriella Scarlatti and Frances Gotch and Britta Wahren and Shattock, {Robin J.}",
year = "2012",
month = "7",
day = "11",
doi = "10.1186/1479-5876-10-144",
language = "English",
pages = "144",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Rational design of HIV vaccines and microbicides

T2 - Report of the EUROPRISE annual conference 2011

AU - Ruffin, Nicolas

AU - Borggren, Marie

AU - Euler, Zelda

AU - Fiorino, Fabio

AU - Grupping, Katrijn

AU - Hallengärd, David

AU - Javed, Aneele

AU - Mendonca, Kevin

AU - Pollard, Charlotte

AU - Reinhart, David

AU - Saba, Elisa

AU - Sheik-Khalil, Enas

AU - Sköld, Annette

AU - Ziglio, Serena

AU - Scarlatti, Gabriella

AU - Gotch, Frances

AU - Wahren, Britta

AU - Shattock, Robin J.

PY - 2012/7/11

Y1 - 2012/7/11

N2 - Europrise is a Network of Excellence supported by the European Commission within the 6th Framework programme from 2007 to 2012. The Network has involved over 50 institutions from 13 European countries together with 3 industrial partners and 6 African countries. The Network encompasses an integrated program of research, training, dissemination and advocacy within the field of HIV vaccines and microbicides. A central and timely theme of the Network is the development of the unique concept of co-usage of vaccines and microbicides. Training of PhD students has been a major task, and some of these post-graduate students have here summarized novel ideas emanating from presentations at the last annual Europrise meeting in Prague. The latest data and ideas concerning HIV vaccine and microbicide studies are included in this review; these studies are so recent that the majority have yet to be published. Data were presented and discussed concerning novel immunisation strategies; microbicides and PrEP (alone and in combination with vaccines); mucosal transmission of HIV/SIV; mucosal vaccination; novel adjuvants; neutralizing antibodies; innate immune responses; HIV/SIV pathogenesis and disease progression; new methods and reagents. These - necessarily overlapping and thought-provoking topics - are comprehensively summarised by the Europrise students in the context of other recent exciting data.

AB - Europrise is a Network of Excellence supported by the European Commission within the 6th Framework programme from 2007 to 2012. The Network has involved over 50 institutions from 13 European countries together with 3 industrial partners and 6 African countries. The Network encompasses an integrated program of research, training, dissemination and advocacy within the field of HIV vaccines and microbicides. A central and timely theme of the Network is the development of the unique concept of co-usage of vaccines and microbicides. Training of PhD students has been a major task, and some of these post-graduate students have here summarized novel ideas emanating from presentations at the last annual Europrise meeting in Prague. The latest data and ideas concerning HIV vaccine and microbicide studies are included in this review; these studies are so recent that the majority have yet to be published. Data were presented and discussed concerning novel immunisation strategies; microbicides and PrEP (alone and in combination with vaccines); mucosal transmission of HIV/SIV; mucosal vaccination; novel adjuvants; neutralizing antibodies; innate immune responses; HIV/SIV pathogenesis and disease progression; new methods and reagents. These - necessarily overlapping and thought-provoking topics - are comprehensively summarised by the Europrise students in the context of other recent exciting data.

UR - http://www.scopus.com/inward/record.url?scp=84863565487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863565487&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-10-144

DO - 10.1186/1479-5876-10-144

M3 - Article

C2 - 22784600

AN - SCOPUS:84863565487

SP - 144

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

ER -